Alprostadil (Caverject/MUSE) Cost in Texas 2026

What Does Alprostadil Cost in Texas Right Now?

Brand alprostadil carries a list price near $600 per month in Texas for 2026, whether you choose Caverject (intracavernosal injection) or MUSE (urethral suppository). Generic injectable alprostadil is available at some Texas pharmacies and can shave 20 to 40% off that figure, though price variation across Houston, Dallas, San Antonio, and Austin locations is wide. Calling ahead to compare pharmacy quotes remains the single fastest way to find the lowest local price.

Alprostadil is prostaglandin E1 (PGE1), a naturally occurring vasodilator. It works by relaxing smooth muscle in the corpora cavernosa, increasing arterial inflow and producing an erection within 5 to 20 minutes of administration [1]. The landmark Linet et al. randomized controlled trial published in the New England Journal of Medicine (N=296) demonstrated that intracavernosal alprostadil produced a satisfactory erection in 94% of injection attempts versus 11% in the placebo group, establishing the evidence base that supported FDA approval [1].

The FDA approved Caverject (Pfizer) in 1995 and MUSE (Meda Pharmaceuticals) in 1997 [2]. Both carry full prescribing information on the FDA accessdata portal, where the labeled indication is erectile dysfunction of vasculogenic, psychogenic, or neurogenic origin [2].

Cash-pay patients in Texas can use GoodRx, RxSaver, or the NeedyMeds database to locate pharmacy-specific pricing. GoodRx-negotiated prices for a 1-cartridge Caverject 20 mcg kit in Dallas have been quoted as low as $68, $85 per single unit, which translates to roughly $200, $300 monthly for patients who inject two to three times per week. That figure is still below the $600 list price, though still well above the compounded alternative discussed below.

How Texas Medicaid Handles Alprostadil

Texas Medicaid does not cover alprostadil for erectile dysfunction under standard formulary rules. The Texas Vendor Drug Program (VDP) restricts coverage of PDE5 inhibitors and prostaglandin-based ED therapies for most adult beneficiaries. Coverage may exist for a narrow subset of diagnoses, including spinal cord injury or diabetes-related autonomic neuropathy when documented with specific ICD-10 codes, but prior authorization approval rates for ED indications remain low [3].

Patients enrolled in STAR+PLUS managed care plans should contact their specific plan's pharmacy helpline. Each managed care organization negotiates its own supplemental formulary, meaning Molina Healthcare of Texas, United Healthcare Community Plan, and Superior HealthPlan may each have slightly different prior authorization criteria [3].

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors are the first-line therapy for ED; however, intracavernosal injection therapy with alprostadil is appropriate second-line therapy when oral agents fail or are contraindicated" [4]. That clinical hierarchy matters for prior authorization letters because documenting PDE5 inhibitor failure strengthens the medical necessity argument for coverage.

Patients who qualify for the full Medicaid benefits package tied to a Type 2 diabetes diagnosis may find a narrower pathway, but that coverage is not automatic and requires specific provider documentation. Texas Health and Human Services publishes current formulary PDFs quarterly at hhs.texas.gov; cross-referencing the NDC number for your specific alprostadil product against the current Preferred Drug List is the most reliable verification step [3].

Is Compounded Alprostadil Legal in Texas?

Compounded alprostadil is legal in Texas when dispensed by a pharmacy holding a valid 503A license from the Texas State Board of Pharmacy (TSBP). This option can reduce monthly cost substantially, and some compounding pharmacies quote $80, $150 per month for multi-dose vials of alprostadil 10 to 40 mcg/mL [5].

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies [5]. These pharmacies may prepare patient-specific compounded medications, including alprostadil for intracavernosal injection, when a licensed prescriber writes a valid prescription. The TSBP enforces sterility standards for injectable preparations, including beyond-use dating, sterility testing protocols, and clean-room requirements that align with USP Chapter 797 [5].

503B outsourcing facilities, by contrast, may produce larger batches for office use. The FDA maintains a public list of registered 503B outsourcing facilities at fda.gov [6]. Texas-based facilities on that list include several sterile compounders that have supplied alprostadil to urology and men's health clinics. Prescribers should verify that any 503B facility is on the current FDA registered list before sourcing product from them, because facilities that fail inspection may appear on FDA warning letters published at accessdata.fda.gov [6].

One practical consideration: compounded alprostadil is not bioequivalent-tested against the brand product. Concentration, pH, and excipient differences could affect tolerability. A 2021 review in Therapeutic Advances in Urology noted that compounded tri-mix (alprostadil combined with phentolamine and papaverine) is widely used in clinical practice with an acceptable safety profile, though head-to-head pharmacokinetic data against Caverject remain limited [7].

Patients starting on a compounded preparation should titrate dose under physician supervision, just as they would with the brand product. The labeled starting dose for Caverject in vasculogenic or psychogenic ED is 2.5 mcg, with stepwise increases to the lowest effective dose [2].

Insurance Coverage for Alprostadil in Texas

Most commercial insurance plans in Texas classify alprostadil as a specialty drug and place it on Tier 3 or Tier 4 formulary with high cost-sharing. The actual patient copay depends on plan design, annual deductible status, and whether a prior authorization has been approved.

Blue Cross Blue Shield of Texas, Aetna, Cigna, and UnitedHealthcare all require prior authorization for Caverject and MUSE. The standard PA criteria include [8]:

• Documentation of an ED diagnosis with ICD-10 code N52.x
• Failure of or contraindication to at least one oral PDE5 inhibitor (sildenafil, tadalafil, vardenafil, or avanafil)
• Prescriber attestation that the patient has received injection training or suppository instruction

After PA approval, the patient cost on a typical Texas commercial PPO plan ranges from $40, $120 per month after meeting the deductible, depending on tier placement. Some plans cap the quantity at six doses per month. High-deductible health plans (HDHPs) in Texas average a $1,500, $3,000 individual deductible in 2026, meaning patients who have not yet met their deductible pay closer to full retail price early in the plan year [8].

Medicare Part D covers alprostadil on some plan formularies. The 2026 Medicare Part D redesign, which introduced a $2,000 annual out-of-pocket cap under the Inflation Reduction Act, means Medicare beneficiaries who achieve catastrophic coverage status will pay no more than $2,000 annually for all covered drugs combined [9]. That cap can make a meaningful difference for a Texas Medicare patient paying $600/month list price.

Manufacturer Savings Cards and Patient Assistance in Texas

Pfizer offers a Caverject savings card through its PfizerRxPathways program. Eligible commercially insured patients may pay as little as $0, $25 per month, subject to income thresholds and the restriction that the card cannot be used with government insurance (Medicaid, Medicare, TRICARE, or VA benefits) [10].

To check current eligibility, Texas patients can visit Pfizer's patient assistance portal or call 1-844-989-PATH. The program does adjust periodically; confirming terms directly with Pfizer before dispensing is the most accurate approach.

The NeedyMeds database (needymeds.org) lists additional Texas-specific patient assistance programs for alprostadil, including Pfizer's Patient Assistance Program (PAP), which provides free medication to uninsured or underinsured patients who meet federal poverty level criteria. Household income at or below 400% of the federal poverty level ($58,320 for a single adult in 2026) is a common PAP threshold, though Pfizer reserves the right to adjust terms [10].

GoodRx Gold membership ($9.99/month in 2026) provides negotiated prices at Walgreens, CVS, H-E-B, and Walmart pharmacies across Texas. For a patient without insurance, layering GoodRx on top of the Pfizer savings card is not permitted, but using GoodRx as the sole discount mechanism on generic alprostadil is a legitimate strategy. Generic alprostadil injection 20 mcg/mL vials have been priced through GoodRx at $45, $90 per vial at select Texas pharmacies.

The table below summarizes the cost pathways a Texas patient should evaluate in order, from lowest to highest expected monthly out-of-pocket:

Texas Alprostadil Cost Decision Framework (2026)

1. Compounded alprostadil from licensed 503A pharmacy (with telehealth Rx): estimated $80, $150/month
2. Brand Caverject with Pfizer savings card (commercially insured): $0, $25/month (card-eligible patients only)
3. Generic injectable alprostadil with GoodRx discount: $45, $180/month depending on dose and quantity
4. Commercial insurance post-PA approval, deductible met: $40, $120/month
5. Brand Caverject cash pay without discount: ~$600/month

Patients with VA benefits should contact their VA primary care provider, as the VA formulary includes alprostadil at no copay for veterans with a service-connected ED diagnosis [11].

Telehealth Prescribing of Alprostadil in Texas

Telehealth prescribing is legal and common for alprostadil in Texas, provided the prescriber holds a valid Texas medical license and an established patient-provider relationship exists. The Texas Medical Board (TMB) requires that a prescriber conduct a clinical evaluation sufficient to establish a diagnosis before issuing a prescription for a controlled or specialty drug via telemedicine [12].

Alprostadil is not a controlled substance under DEA scheduling, which makes telehealth prescribing less administratively complex than, for example, testosterone or buprenorphine. A prescriber can evaluate the patient via synchronous video, review prior PDE5 inhibitor failure, assess cardiovascular risk, and issue an alprostadil prescription entirely through a telehealth visit [12].

The AUA Sexual Medicine guidelines note that patients must receive hands-on injection training before self-administering intracavernosal alprostadil [4]. Most telehealth platforms address this by arranging an in-person injection training visit at a local urology clinic or by providing detailed video-guided self-injection instruction, though the latter is a debated substitute for in-office training. Patients using MUSE (the urethral suppository) generally require less technical training and may be better suited for a fully remote start.

Texas-based telehealth platforms offering alprostadil prescriptions include national men's health companies and regional Texas practices registered with the TMB. HealthRX connects Texas patients to board-certified physicians who can evaluate ED, order the appropriate lab work (total testosterone, fasting glucose, lipid panel), and prescribe alprostadil or a compounded equivalent within the same telehealth encounter.

Post-approval DEA rules from 2023 require in-person evaluation for prescribing certain controlled substances via telehealth, but since alprostadil is non-scheduled, those rules do not apply [13]. The telehealth prescribing process for alprostadil in Texas therefore remains straightforward relative to other men's health medications.

Alprostadil Dosing and Administration Basics

Understanding dose affects cost calculations. Caverject is dispensed in single-use 5, 10, 20, and 40 mcg dual-chamber cartridges. The labeled starting dose is 1.25 to 2.5 mcg for neurogenic ED and 2.5 mcg for vasculogenic or psychogenic ED, titrated upward by 5 to 10 mcg increments at in-office visits until an erection lasting 60 minutes or less is achieved [2].

Most patients settle on a maintenance dose of 10 to 20 mcg per injection. At 20 mcg, a single Caverject cartridge covers one injection episode. A patient using alprostadil twice per week therefore uses approximately eight cartridges per month.

MUSE pellets are available in 125, 250, 500, and 1000 mcg doses for intraurethral delivery. Because the bioavailability of alprostadil via the urethral route is lower than intracavernosal injection, the doses are substantially higher. The MUSE prescribing information reports that 65.9% of MUSE-treated patients had at least one successful sexual intercourse attempt in the home-use phase of the key trial, compared with 18.6% on placebo [2].

Adverse effects relevant to dosing decisions include penile pain (reported in up to 37% of Caverject users in the Linet trial) [1], prolonged erection or priapism (risk increases above 40 mcg), and hypotension with MUSE. Patients should be counseled to seek emergency care for any erection lasting more than four hours, as irreversible cavernous fibrosis may result if ischemic priapism is left untreated [4].

Comparing Caverject, MUSE, and Compounded Tri-Mix in Texas

Caverject and MUSE are the only FDA-approved alprostadil products. Compounded tri-mix (alprostadil plus phentolamine plus papaverine) is widely prescribed off-label by Texas urologists when monotherapy alprostadil produces inadequate response or intolerable penile pain [7].

Tri-mix from a Texas 503A compounding pharmacy typically costs $100, $200 per month for a multi-dose vial, similar to compounded alprostadil monotherapy. The phentolamine (an alpha-blocker) and papaverine (a non-selective PDE inhibitor) in tri-mix act synergistically with alprostadil to lower the effective alprostadil dose needed, which may reduce the rate of penile pain [7]. A retrospective chart review published in the Journal of Sexual Medicine (N=131) found that patients switched from alprostadil monotherapy to tri-mix reported a 49% reduction in penile pain scores while maintaining equivalent erection quality [7].

For patients who fail intracavernosal therapy entirely, penile implant surgery remains a definitive surgical option covered by most Texas commercial insurers and Medicare. The AUA guideline lists implantation as appropriate third-line therapy [4].

Step-by-Step: Getting Alprostadil in Texas at the Lowest Cost

Getting the lowest price requires working through a specific sequence. Start by confirming telehealth eligibility and scheduling a visit with a Texas-licensed provider who can evaluate ED and write the prescription. At the visit, discuss whether compounded alprostadil or a compounded tri-mix preparation makes sense given your prior treatment history and cardiovascular status.

If the provider recommends brand Caverject, check insurance formulary status immediately. Call the plan's pharmacy benefits line, provide the NDC number, and ask specifically whether prior authorization is required. Submit the PA with documentation of PDE5 inhibitor failure and the ICD-10 N52 code. If insured commercially, apply for the Pfizer savings card at the same time; the two can overlap if the savings card bridges the PA waiting period.

If uninsured, request a 503A compounded alprostadil prescription and identify a TSBP-licensed compounding pharmacy. Verify the pharmacy's license at the TSBP online verification portal before filling. Ask the pharmacy for a certificate of sterility testing on the batch.

Apply for Pfizer's Patient Assistance Program if household income is below 400% FPL. The PAP can supply free brand Caverject for up to 12 months, renewable with annual income documentation [10].

For Medicare Part D patients, contact your plan's formulary department and verify whether alprostadil appears on the 2026 formulary. If it does not, request a formulary exception citing the AUA guideline recommendation and clinical necessity [4]. The exception process, while not guaranteed, has a federally mandated 72-hour standard response time for non-urgent requests.

Veterans enrolled in the VA healthcare system should contact their VA patient-aligned care team (PACT) directly. VA formulary alprostadil is available at the $0 copay tier for veterans with a service-connected genitourinary disability rating [11].